We included PANoptotic cluster and clinical characteristics, such as age, histology, IDH mutation, 1p/19q co-deletion, and MGMT promoter methylation into multivariate Cox regression analysis and found that PANoptotic cluster is an independent factor affecting the prognosis of glioma patients (Supplementary Figure S2A). The gene discussed is MGMT; the disease is glioma.